EQ

1.0605.36%
MM

Michael Moore

Vice President of Investor Relations & Corporate Communications

Mr. Michael Moore serves as Vice President of Investor Relations & Corporate Communications at Equillium, Inc. He served as Vice President of Investor Relations and Corporate Communications at Oncolytics Biotech Inc. since February 20, 2017 until June 4, 2020. Mr. Moore served as Vice President of US Operations and Practice Leader of Health and Biotech at NATIONAL Equicom Inc until March 3, 2017. He is a financial communications specialist with in Investor Relations and corporate communications. He bridges the gap between companies and the investment community, developing IR strategies that help clients raise visibility in the capital markets, improve liquidity and achieve a fair market valuation. He has managed countless Analyst and Investor days and executed hundreds of road shows. He’s created presentations, collateral materials and websites and written many conference call speeches.

Positions